|
Name |
N-(2-hydroxy-2-phenylethyl)acetamide
|
Molecular Formula | C10H13NO2 | |
IUPAC Name* |
N-(2-hydroxy-2-phenylethyl)acetamide
|
|
SMILES |
CC(=O)NCC(C1=CC=CC=C1)O
|
|
InChI |
InChI=1S/C10H13NO2/c1-8(12)11-7-10(13)9-5-3-2-4-6-9/h2-6,10,13H,7H2,1H3,(H,11,12)
|
|
InChIKey |
KJCJYQYRPOJUKJ-UHFFFAOYSA-N
|
|
Synonyms |
N-(2-hydroxy-2-phenylethyl)acetamide; 3306-05-6; N-(2-hydroxy-2-phenyl-ethyl)-acetamide; NSC114228; SCHEMBL885090; DTXSID90297124; AKOS008977316; alpha-(Acetylaminomethyl)benzyl alcohol; HY-W164451; NSC-114228; DS-011544; CS-0221825; EN300-100177; N-(2-HYDROXY-2-PHENYL-ETHYL)ACETAMIDE; Z255306774
|
|
CAS | 3306-05-6 | |
PubChem CID | 270963 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 179.22 | ALogp: | 0.4 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 49.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.734 |
Caco-2 Permeability: | -4.605 | MDCK Permeability: | 0.00002670 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.102 |
Human Intestinal Absorption (HIA): | 0.067 | 20% Bioavailability (F20%): | 0.065 |
30% Bioavailability (F30%): | 0.806 |
Blood-Brain-Barrier Penetration (BBB): | 0.843 | Plasma Protein Binding (PPB): | 11.56% |
Volume Distribution (VD): | 0.911 | Fu: | 76.22% |
CYP1A2-inhibitor: | 0.073 | CYP1A2-substrate: | 0.095 |
CYP2C19-inhibitor: | 0.06 | CYP2C19-substrate: | 0.812 |
CYP2C9-inhibitor: | 0.012 | CYP2C9-substrate: | 0.101 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.337 |
CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.196 |
Clearance (CL): | 3.69 | Half-life (T1/2): | 0.718 |
hERG Blockers: | 0.035 | Human Hepatotoxicity (H-HT): | 0.227 |
Drug-inuced Liver Injury (DILI): | 0.031 | AMES Toxicity: | 0.071 |
Rat Oral Acute Toxicity: | 0.015 | Maximum Recommended Daily Dose: | 0.092 |
Skin Sensitization: | 0.147 | Carcinogencity: | 0.022 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.047 |
Respiratory Toxicity: | 0.023 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000173 | 0.561 | D00HHS | 0.468 | ||||
ENC000693 | 0.522 | D0LG8E | 0.468 | ||||
ENC001819 | 0.500 | D0R1CR | 0.408 | ||||
ENC001934 | 0.467 | D05OFX | 0.387 | ||||
ENC001960 | 0.467 | D0X9RY | 0.386 | ||||
ENC000218 | 0.455 | D0O6IU | 0.380 | ||||
ENC000717 | 0.453 | D00DZN | 0.377 | ||||
ENC000191 | 0.452 | D05OIS | 0.372 | ||||
ENC000192 | 0.452 | D0P6UB | 0.367 | ||||
ENC000326 | 0.448 | D01ZJK | 0.367 |